Document is current

Article History

Received: 19 April 2024

Accepted: 2 July 2024

First Online: 2 August 2024

Declarations

:

: Damiano Paolicelli, Giovanna Borriello, Raffaella Clerici, Elena Colombo, Davide Croce, Emanuele D’Amico, Nicola De Rossi, Alessia Di Sapio, Giuseppe Fenu, Davide Maimone, Girolama A. Marfia, Marcello Moccia, Paola Perini, Maria G. Piscaglia, Lorenzo Razzolini, Massimo Riccaboni, Elisabetta Signoriello, Carla Tortorella received honoraria from Sanofi S.r.l. to participate in the study. Giovanna Borriello received fees for participating to Advisory Boards and travel compensations from Almirall, Biogen, Bristol-Myers Squibb, Johnson and Johnson, Merck, Novartis, Roche, and Sanofi. Elena Colombo reports travel expenses, speaker honoraria, and advisory board work from Alexion, Biogen, Bristol-Myers Squibb, Janssen, Merck, Novartis, Roche, and Sanofi. Alessia Di Sapio received speaker and consulting personal compensation by Alexion, Alnylam, Amgen Biogen, Bristol-Myers Squibb, Janssen, Merck Serono, Novartis, Roche, and Sanofi and received reimbursement for attending conferences by Biogen, Merck Serono, Novartis, Roche, and Sanofi. Davide Maimone received honoraria for participating to Advisory Boards and lectures and received travel grants from Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, and Sanofi. Giuseppe Fenu received honoraria for consultancy or speaking from Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, and Sanofi. Marcello Moccia has received financial support by the MUR PNRR Extended Partnership (MNESYS no. PE00000006, and DHEAL-COM no. PNC-E3-2022-23683267), research grants from the ECTRIMS-MAGNIMS, the UK MS Society, and Merck, and honoraria from Biogen, Bristol-Myers Squibb, Ipsen, Janssen, Merck, Novartis, Roche, and Sanofi. Elisabetta Signoriello received travel grants and performed consultancy for Almirall, Biogen, Bristol-Myers Squibb, Novartis, Merck, Roche, Sanofi, and Teva. Carla Tortorella received travel funding and/or speaker honoraria from Alexion, Almirall, Biogen, Bristol-Myers Squibb, Horizon, Merck, Novartis, Roche, and Sanofi.

: No ethical committee approval was required for this study. All databases used in the study are property of IQVIA^® and are accessible by its employees at any time.